Sign inGet started

Longitude Capital Partners II, LLC

Insider CIK 1647491 · RPID 10% owner · KALA 10% owner · TCDA 10% owner · AIMT 10% owner · APTX 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RPID RAPID MICRO BIOSYSTEMS, IN S Sale2026-02-042026-02-0649,000$3.88 $190.1K0SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN S Sale2026-02-032026-02-0327,500$4.24 $116.6K49,000SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN S Sale2026-02-022026-02-0327,500$4.25 $116.9K76,500SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN S Sale2026-01-302026-02-0346,000$4.54 $208.8K104,000SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN X Exercise deriv2026-01-232026-02-03500,000— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN X Exercise deriv2026-01-232026-02-03129,032— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN S Sale2026-01-232026-02-037,739$4.06 $31.4K4,029,245SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN X Exercise2026-01-232026-02-03629,032$0.05 $31.5K4,036,984SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-202,291,665— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-20500,000— $0500,000SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-202,500,000— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-20645,160— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-205,654,529— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-208,774,007— $00SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion deriv2021-07-192021-07-20129,032— $0129,032SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN C Conversion2021-07-192021-07-203,344,038— $03,407,952SEC↗
RPID RAPID MICRO BIOSYSTEMS, IN P Buy2021-07-192021-07-20150,000$20.00 $3.00M150,000SEC↗
TCDA Tricida, Inc. C Conversion deriv2018-07-022018-07-029,677,419— $00SEC↗
TCDA Tricida, Inc. C Conversion deriv2018-07-022018-07-021,817,447— $00SEC↗
TCDA Tricida, Inc. C Conversion2018-07-022018-07-022,431,511— $02,431,511SEC↗
TCDA Tricida, Inc. C Conversion2018-07-022018-07-02456,644— $02,888,155SEC↗
TCDA Tricida, Inc. P Buy2018-07-022018-07-02131,579$19.00 $2.50M3,019,734SEC↗
APTX Aptinyx Inc. C Conversion deriv2018-06-252018-06-2621,946,301— $00SEC↗
APTX Aptinyx Inc. C Conversion deriv2018-06-252018-06-2633,022,786— $00SEC↗
APTX Aptinyx Inc. C Conversion deriv2018-06-252018-06-2628,895,188— $00SEC↗
APTX Aptinyx Inc. C Conversion2018-06-252018-06-26795,553— $03,040,079SEC↗
APTX Aptinyx Inc. C Conversion2018-06-252018-06-261,047,450— $01,047,450SEC↗
APTX Aptinyx Inc. P Buy2018-06-252018-06-26150,000$16.00 $2.40M3,190,079SEC↗
APTX Aptinyx Inc. C Conversion2018-06-252018-06-261,197,076— $02,244,526SEC↗
KALA Kala Pharmaceuticals, Inc. C Conversion deriv2017-07-252017-07-2710,707,985— $00SEC↗
KALA Kala Pharmaceuticals, Inc. C Conversion2017-07-252017-07-272,055,946— $02,055,946SEC↗
KALA Kala Pharmaceuticals, Inc. P Buy2017-07-252017-07-27215,000$15.00 $3.23M2,270,946SEC↗
AIMT Aimmune Therapeutics, Inc. J Other2016-11-292016-12-017,276— $07,276SEC↗
AIMT Aimmune Therapeutics, Inc. J Other2016-11-292016-12-011,500,000— $06,013,134SEC↗
AIMT Aimmune Therapeutics, Inc. P Buy2016-03-292016-03-3145,440$14.15 $643.0K7,513,134SEC↗
AIMT Aimmune Therapeutics, Inc. P Buy2016-03-292016-03-3133,064$13.50 $446.4K7,467,694SEC↗
AIMT Aimmune Therapeutics, Inc. C Conversion deriv2015-08-112015-08-113,873,530— $00SEC↗
AIMT Aimmune Therapeutics, Inc. C Conversion deriv2015-08-112015-08-113,248,600— $00SEC↗
AIMT Aimmune Therapeutics, Inc. C Conversion2015-08-112015-08-113,873,530— $03,873,530SEC↗
AIMT Aimmune Therapeutics, Inc. P Buy2015-08-112015-08-11312,500$16.00 $5.00M7,434,630SEC↗
AIMT Aimmune Therapeutics, Inc. C Conversion2015-08-112015-08-113,248,600— $07,122,130SEC↗